tiprankstipranks
Trending News
More News >
RaQualia Pharma Inc. (JP:4579)
:4579
Japanese Market

RaQualia Pharma Inc. (4579) Income Statement

Compare
1 Followers

RaQualia Pharma Inc. Income Statement

Last quarter (Q4 2025), RaQualia Pharma Inc.'s total revenue was ¥1.67B, an increase of 126.10% from the same quarter last year. In Q4, RaQualia Pharma Inc.'s net income was ¥842.10M. See RaQualia Pharma Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 3.98B¥ 3.11B¥ 1.90B¥ 2.92B¥ 2.78B
Gross Profit
¥ 3.27B¥ 2.48B¥ 1.66B¥ 2.69B¥ 2.46B
Operating Expenses
¥ 2.78B¥ 2.70B¥ 1.99B¥ 1.82B¥ 1.75B
Depreciation and Amortization
¥ 488.16M¥ 401.65M¥ 175.56M¥ 147.73M¥ 141.56M
EBITDA
¥ 971.88M¥ 188.27M¥ -111.80M¥ 1.00B¥ 1.02B
Operating Income
¥ 483.72M¥ -213.38M¥ -337.37M¥ 866.24M¥ 707.86M
Other Income/Expenses
¥ -45.77M¥ -144.35M¥ 43.32M¥ -15.22M¥ 172.72M
Pretax Income
¥ 437.95M¥ -357.73M¥ -294.05M¥ 851.01M¥ 880.58M
Net Income
¥ 273.12M¥ -495.03M¥ -323.66M¥ 723.39M¥ 755.79M
Per Share Metrics
Basic EPS
¥ 11.53¥ -22.87¥ -14.98¥ 34.50¥ 36.07
Diluted EPS
¥ 11.36¥ -22.87¥ -14.98¥ 34.47¥ 36.04
Weighted Average Shares Outstanding
23.69M 21.65M 21.61M 20.97M 20.95M
Weighted Average Shares Outstanding (Diluted)
24.04M 21.65M 21.61M 20.98M 20.97M
Currency in JPY

RaQualia Pharma Inc. Earnings and Revenue History